212 related articles for article (PubMed ID: 33087489)
1. FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in rats.
Zhang SY; Li RJW; Lim YM; Batchuluun B; Liu H; Waise TMZ; Lam TKT
Gut; 2021 Sep; 70(9):1675-1683. PubMed ID: 33087489
[TBL] [Abstract][Full Text] [Related]
2. Small intestinal taurochenodeoxycholic acid-FXR axis alters local nutrient-sensing glucoregulatory pathways in rats.
Waise TMZ; Lim YM; Danaei Z; Zhang SY; Lam TKT
Mol Metab; 2021 Feb; 44():101132. PubMed ID: 33264656
[TBL] [Abstract][Full Text] [Related]
3. An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.
Gonzalez FJ; Jiang C; Patterson AD
Gastroenterology; 2016 Nov; 151(5):845-859. PubMed ID: 27639801
[TBL] [Abstract][Full Text] [Related]
4. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
[TBL] [Abstract][Full Text] [Related]
5. FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid.
Friedman ES; Li Y; Shen TD; Jiang J; Chau L; Adorini L; Babakhani F; Edwards J; Shapiro D; Zhao C; Carr RM; Bittinger K; Li H; Wu GD
Gastroenterology; 2018 Dec; 155(6):1741-1752.e5. PubMed ID: 30144429
[TBL] [Abstract][Full Text] [Related]
6. Taurochenodeoxycholic acid inhibits intestinal epithelial cell proliferation and induces apoptosis independent of the farnesoid X receptor.
Liu Y; Niu K; Wang R; Liang X; Lin C; Wu X; Zhai Z
Food Funct; 2023 Jun; 14(11):5277-5289. PubMed ID: 37195071
[TBL] [Abstract][Full Text] [Related]
7. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
8. Peripheral and central regulation of insulin by the intestine and microbiome.
Schertzer JD; Lam TKT
Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E234-E239. PubMed ID: 33308015
[TBL] [Abstract][Full Text] [Related]
9. An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice.
Xie C; Jiang C; Shi J; Gao X; Sun D; Sun L; Wang T; Takahashi S; Anitha M; Krausz KW; Patterson AD; Gonzalez FJ
Diabetes; 2017 Mar; 66(3):613-626. PubMed ID: 28223344
[TBL] [Abstract][Full Text] [Related]
10. Melatonin relieves hepatic lipid dysmetabolism caused by aging via modifying the secondary bile acid pattern of gut microbes.
Wei D; Li Y; Che M; Li C; Wu Q; Sun C
Cell Mol Life Sci; 2022 Sep; 79(10):527. PubMed ID: 36151409
[TBL] [Abstract][Full Text] [Related]
11. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition.
Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ
Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191
[TBL] [Abstract][Full Text] [Related]
13. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery.
Albaugh VL; Banan B; Antoun J; Xiong Y; Guo Y; Ping J; Alikhan M; Clements BA; Abumrad NN; Flynn CR
Gastroenterology; 2019 Mar; 156(4):1041-1051.e4. PubMed ID: 30445014
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus gasseri in the Upper Small Intestine Impacts an ACSL3-Dependent Fatty Acid-Sensing Pathway Regulating Whole-Body Glucose Homeostasis.
Bauer PV; Duca FA; Waise TMZ; Dranse HJ; Rasmussen BA; Puri A; Rasti M; O'Brien CA; Lam TKT
Cell Metab; 2018 Mar; 27(3):572-587.e6. PubMed ID: 29514066
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mitochondrial fission and iNOS in the dorsal vagal complex protects from overeating and weight gain.
Patel B; New LE; Griffiths JC; Deuchars J; Filippi BM
Mol Metab; 2021 Jan; 43():101123. PubMed ID: 33227495
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
Xu M; Shen Y; Cen M; Zhu Y; Cheng F; Tang L; Zheng X; Kim JJ; Dai N; Hu W
J Crohns Colitis; 2021 Jul; 15(7):1197-1210. PubMed ID: 33417675
[TBL] [Abstract][Full Text] [Related]
18. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
Jiang C; Xie C; Li F; Zhang L; Nichols RG; Krausz KW; Cai J; Qi Y; Fang ZZ; Takahashi S; Tanaka N; Desai D; Amin SG; Albert I; Patterson AD; Gonzalez FJ
J Clin Invest; 2015 Jan; 125(1):386-402. PubMed ID: 25500885
[TBL] [Abstract][Full Text] [Related]
19. Capsaicin Improves Glucose Tolerance and Insulin Sensitivity Through Modulation of the Gut Microbiota-Bile Acid-FXR Axis in Type 2 Diabetic db/db Mice.
Hui S; Liu Y; Chen M; Wang X; Lang H; Zhou M; Yi L; Mi M
Mol Nutr Food Res; 2019 Dec; 63(23):e1900608. PubMed ID: 31539192
[TBL] [Abstract][Full Text] [Related]
20. Effect of simvastatin on the expression of farnesoid X receptor in diabetic animal models of altered glucose homeostasis.
Wang L; Huang X; Hu S; Ma X; Wang S; Pang S
Chin Med J (Engl); 2014; 127(2):218-24. PubMed ID: 24438607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
